Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation (PyramIDH)
NCT 06465953 Brief Summary This study will enroll participants with myelodysplastic syndromes…
Read more arrow_forward